Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /EPiServer/CMS/ Disallow: /Util/ Sitemap: https://www.oncopeptides.com/Sitemap.xml |
Title | Oncopeptides |
Description | Bringing hope through Oncopeptides is a rapidly growing biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is science driven and committed to bringing innovation to patients with an unmet medical |
Keywords | N/A |
WebSite | oncopeptides.com |
Host IP | 217.114.85.70 |
Location | Sweden |
Site | Rank |
US$3,894,582
Last updated: 2022-06-27 03:06:10
oncopeptides.com has Semrush global rank of 2,717,700. oncopeptides.com has an estimated worth of US$ 3,894,582, based on its estimated Ads revenue. oncopeptides.com receives approximately 449,375 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.70. According to SiteAdvisor, oncopeptides.com is safe to visit. |
Purchase/Sale Value | US$3,894,582 |
Daily Ads Revenue | US$3,595 |
Monthly Ads Revenue | US$107,850 |
Yearly Ads Revenue | US$1,294,200 |
Daily Unique Visitors | 29,959 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
oncopeptides.com. | A | 600 | IP: 217.114.85.70 |
oncopeptides.com. | NS | 600 | NS Record: ns2.aname.net. |
oncopeptides.com. | NS | 600 | NS Record: ns3.aname.se. |
oncopeptides.com. | NS | 600 | NS Record: ns.aname.net. |
oncopeptides.com. | MX | 3600 | MX Record: 0 oncopeptides-com.mail.protection.outlook.com. |
oncopeptides.com. | TXT | 3600 | TXT Record: apple-domain-verification=lKnfqYVN6D3FQ9F2 |
oncopeptides.com. | TXT | 3600 | TXT Record: MS=ms33385465 |
oncopeptides.com. | TXT | 3600 | TXT Record: google-site-verification=x2GSArWw-6TfDw-9hfT-3gqMG2t-cPtBOyLSn_p2Ns4 |
oncopeptides.com. | TXT | 3600 | TXT Record: v=spf1 ip4:5.150.217.10 ip4:38.122.195.218 ip4:96.89.225.29 ip4:64.71.27.110 ip4:98.128.210.198 ip4:50.211.217.93 ip4:74.84.203.40 ip4:128.136.57.196 ip4:74.84.203.38 include:spf.protection.outlook.com -all |
oncopeptides.com. | TXT | 3600 | TXT Record: google-site-verification=H_C9ikPYbU8quPQCuRZhNtwKfWVPMBjarwWptzMEoAA |
HC: Skip to main content Go to the home page Close navigation Global Loading... Search Company Company Our history Our history Founders The founders of Oncopeptides awarded Strategy Organization Board of Directors Leadership Governance Governance Corporate Governance reports Governance structure General meeting General meeting Annual General Meeting 2022 General Meetings Nomination committee Nomination committee Nomination Committee 2022 Nomination committees The Board of Directors The Board of Directors Board of Directors Board committees Work of the Board of Directors Senior Management Remuneration Remuneration Remuneration reports Auditors Internal control Articles of association Innovation Innovation Technology platform Technology platform Investigational Drug Mechanism of action Research Areas Research Areas Multiple Myeloma Intellectual Property Pipeline Pipeline Clinical Development Regulatory strategy O-12-M1 HORIZON OCEAN ANCHOR BRIDGE ASCENT PORT LIGHTHOUSE Early Access |
HTTP/1.0 301 Moved Permanently Location: http://www.oncopeptides.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Mon, 25 Oct 2021 18:48:18 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 152 Connection: close Location: https://www.oncopeptides.com/ X-Powered-By: ASP.NET Set-Cookie: ARRAffinity=0b3e7bab7bc253429b01a84fcfe52f9eaf7487da416b1f2a0af2bf3349b35509;Path=/;HttpOnly;Domain=www.oncopeptides.com CF-Cache-Status: DYNAMIC Server: cloudflare CF-RAY: 6a3d9e47eb3e2b5f-ORD HTTP/2 301 date: Mon, 25 Oct 2021 18:48:18 GMT content-type: text/html; charset=UTF-8 content-length: 154 location: https://www.oncopeptides.com/en x-powered-by: ASP.NET set-cookie: ARRAffinity=5a000a325532e330eccf178c223dcda91307b801d0f04e36c74424b6f6e3bbc1;Path=/;HttpOnly;Secure;Domain=www.oncopeptides.com set-cookie: ARRAffinitySameSite=5a000a325532e330eccf178c223dcda91307b801d0f04e36c74424b6f6e3bbc1;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.oncopeptides.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a3d9e49df5d2c34-ORD HTTP/2 200 date: Mon, 25 Oct 2021 18:48:18 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=wtjn0qsdm2c5is0bpduxgddr; path=/; HttpOnly; SameSite=Lax x-aspnet-version: 4.0.30319 strict-transport-security: max-age=31536000 request-context: appId=cid-v1:4f6ea5df-d3e2-4c86-a01a-dc25ed36cc19 access-control-expose-headers: Request-Context x-powered-by: ASP.NET set-cookie: ARRAffinity=5a000a325532e330eccf178c223dcda91307b801d0f04e36c74424b6f6e3bbc1;Path=/;HttpOnly;Secure;Domain=www.oncopeptides.com set-cookie: ARRAffinitySameSite=5a000a325532e330eccf178c223dcda91307b801d0f04e36c74424b6f6e3bbc1;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.oncopeptides.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a3d9e4c6b592c34-ORD |
Domain Name: ONCOPEPTIDES.COM Registry Domain ID: 1923738578_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namesrs.com Registrar URL: http://www.namesrs.com Updated Date: 2021-02-26T14:46:01Z Creation Date: 2015-04-27T11:28:54Z Registry Expiry Date: 2022-04-27T11:28:54Z Registrar: Name SRS AB Registrar IANA ID: 638 Domain Status: ok https://icann.org/epp#ok Name Server: NS.ANAME.NET Name Server: NS2.ANAME.NET Name Server: NS3.ANAME.SE DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T21:29:18Z <<< |